Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Longevity
Synthetic pineal tetrapeptide that activates telomerase and modulates melatonin production.
Peptide B
Cosmetic
Copper-binding tripeptide with potent wound-healing, skin-remodeling, and gene-regulatory properties.
Typical vial
10 mg
Typical dose
5000-10000 mcg
Half-life
~30 minutes (short half-life but biological effects persist due to gene expression changes)
FDA status
Not FDA approved for human use. No clinical trials submitted…
Typical vial
50 mg
Typical dose
200-500 mcg
Half-life
~30-60 minutes (plasma)
FDA status
Not FDA approved as a drug. Widely used as a cosmetic ingred…
Epithalon effects
GHK-Cu effects
Epithalon side effects
GHK-Cu side effects
Epithalon dosing ranges
Anti-aging and telomere support
5-10 mg · Once daily (SubQ) · 10-20 days, repeated 1-2 times per year
GHK-Cu dosing ranges
Skin rejuvenation (topical)
1-2% concentration · Once or twice daily · Ongoing
Systemic tissue support (SubQ)
200-500 mcg · Once daily · 4-6 weeks
Wound healing support (SubQ)
200-500 mcg · Once daily near wound site · 2-4 weeks
Epithalon: Synthetic pineal tetrapeptide that activates telomerase and modulates melatonin production. Typical dose 5000-10000 mcg. GHK-Cu: Copper-binding tripeptide with potent wound-healing, skin-remodeling, and gene-regulatory properties. Typical dose 200-500 mcg. Both fall under the Longevity and Cosmetic categories.
Stacking Epithalon with GHK-Cu is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
Epithalon is typically dosed: Once daily (SubQ) for Anti-aging and telomere support. GHK-Cu is typically dosed: Once or twice daily for Skin rejuvenation (topical); Once daily for Systemic tissue support (SubQ); Once daily near wound site for Wound healing support (SubQ).
Epithalon: Not FDA approved for human use. No clinical trials submitted to the FDA. GHK-Cu: Not FDA approved as a drug. Widely used as a cosmetic ingredient without requiring drug approval for topical formulations.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free